World's Best Scientists 2026 revealed!
Hitomi Sezaki

Hitomi Sezaki

D-Index & Metrics

Microbiology

D-Index
56
Citations
11391
World Ranking
3701
National Ranking
147

Hitomi Sezaki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Hitomi Sezaki sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 274 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Hitomi Sezaki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Hitomi Sezaki sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Hitomi Sezaki is affiliated with Toranomon Hospital in Japan and has contributed extensively to medical research, particularly in the field of hepatology. Their academic work spans a range of topics focused on liver diseases, cancer treatment, and liver-related diagnostic techniques.

The main fields of study for Sezaki include Medicine, with a strong focus on subfields such as Hepatology, Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging, and Endocrinology, Diabetes and Metabolism.

The primary research topics covered in Sezaki's work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease and Transplantation
  • Pancreatic and Hepatic Oncology Research
  • MRI in Cancer Diagnosis

Sezaki has published in various scientific venues, with frequent contributions to the following journals:

  • Oncology
  • Hepatology Research
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • Kanzo

Among the recent papers authored are:

  • Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis, 2020, The Lancet. Gastroenterology & Hepatology
  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis, 2021, Med
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine
  • Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis, 2020, Liver Cancer

Sezaki's research collaborations include frequent co-authors such as Hiromitsu Kumada, Tetsuya Hosaka, Yusuke Kawamura, Norio Akuta, and Fumitaka Suzuki. These collaborative works contribute to the interdisciplinary approach spanning hepatology, oncology, and clinical medicine.

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

    Kazuaki Chayama;C. Nelson Hayes;Hiromi Abe;Daiki Miki

  • Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

    Masahiro Kobayashi;Fumitaka Suzuki;Shunichiro Fujiyama;Yusuke Kawamura

  • Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

    Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta;Yoshiyuki Suzuki

  • Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up☆

    Hiromi Yatsuji;Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta

  • Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.

    Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta;Hitomi Sezaki

  • Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies.

    Norio Akuta;Chizuru Watanabe;Yusuke Kawamura;Yasuji Arase

  • Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus

    Norio Akuta;Yusuke Kawamura;Chizuru Watanabe;Akihiro Nishimura

  • Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.

    Hitomi Sezaki;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Yasuji Arase
Yasuji Arase University of Yamanashi
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Yuzo Miyakawa
Yuzo Miyakawa Miyakawa Memorial Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in microbiology opens doors to diverse career paths, many of which can be complemented by related online degrees. For individuals with unique circumstances, such as those seeking the best associate degrees for felons, online programs offer flexible options to build skills and re-enter the workforce effectively.

Healthcare is a prominent field linked to microbiology. For example, becoming a functional medicine nurse practitioner involves advanced knowledge of biology and patient care, making it a suitable transition for microbiology graduates interested in clinical roles. Similarly, the field of medical coding provides alternative career pathways. Earning certification as a certified professional coder (CPC) allows you to work in healthcare administration, combining detail orientation with healthcare knowledge.

Another growing sector is health information management. This career requires expertise in managing patient data and health records, often supported by backgrounds in science and technology. Understanding the health information management job description and salary can help you assess if this path aligns with your career goals.

Exploring these related degrees and career options can enhance your opportunities and provide valuable alternatives within the biomedical and healthcare industries.

Best Scientists Citing Hitomi Sezaki

Trending Scientists

Recently Published Articles